Novonesis stock starts EUR 1 billion buyback program and trades steady

Published on 09/16/2026 at 15:38 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Novonesis stock is underpinned by a new multi-year share buyback program of up to EUR 1 billion announced on September 16, 2026. The shares closed at DKK 275.90 on September 15, 2026, within a price range implied by recent buyback transactions.

Industrieanlage mit Fermentationstanks eines daenischen Biotech-Unternehmens — Fotorealistische Ansicht einer Biotech-Anlage von Novonesis (Novozymes), ISIN DK0060336014, mit modernen Fermentationstanks in Bagsvaerd, Illustration mit AI erstellt.

Novonesis stock (ISIN DK0060336014) is drawing investor attention after the Danish biosolutions group kicked off the first tranche of a planned EUR 1 billion multi-year share buyback program on September 16, 2026, based on a closing price of DKK 275.90 per B share on Nasdaq Copenhagen on September 15, 2026.

Buyback program supports Novonesis valuation

According to Globenewswire on September 16, 2026, Novonesis initiated the first tranche of its EUR 1 billion multi-year share buyback program, with the initial tranche set at up to EUR 75 million and expected to run until no later than December 17, 2026.

The company stated that, based on the closing share price on September 11, 2026, the first tranche corresponds to around 1.3 million B shares, giving investors a concrete sense of the expected reduction in free float during this period.Globenewswire

Recent trading levels and buyback pricing context

Per data cited by a Danish market wrap on September 16, 2026, Novonesis B shares closed at DKK 275.90 on Nasdaq Copenhagen on September 15, 2026, a level that sits modestly below the average price of recent buyback transactions at DKK 281.89 per B share disclosed earlier in the buyback communication.

This implies that the stock was trading about 2.1 percent below the average buyback transaction price of DKK 281.89 as of the September 15, 2026 close, a gap that may be relevant for investors assessing the program’s potential accretion and signaling effect.Globenewswire

Stock price snapshot and investor perspective

At the close of trading on September 15, 2026, Novonesis stock changed hands at DKK 275.90 on Nasdaq Copenhagen, with the session ending slightly below recent buyback transaction averages and highlighting how the market continues to digest the EUR 1 billion repurchase framework.